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Abstract. 
 
We tested the hypothesis that the albumin-
docking protein gp60, which is localized in caveolae, 
 
couples to the heterotrimeric GTP binding protein G
 
i
 
, 
and thereby activates plasmalemmal vesicle formation 
and the directed migration of vesicles in endothelial 
cells (ECs). We used the water-soluble styryl pyridinium 
 
dye 
 
N
 
-(3-triethylaminopropyl)-4-(p-dibutylaminostyryl) 
pyridinium dibromide
 
 
 
(FM 1-43) to quantify vesicle traf-
ﬁcking by confocal and digital ﬂuorescence microscopy. 
FM 1-43 and ﬂuorescently labeled anti-gp60 antibody 
(Ab) were colocalized in endocytic vesicles within 5 min 
of gp60 activation. Vesicles migrated to the basolateral 
surface where they released FM 1-43, the ﬂuid phase 
styryl probe. FM 1-43 ﬂuorescence disappeared from 
the basolateral EC surface without the loss of anti-gp60 
Ab ﬂuorescence. Activation of cell-surface gp60 by 
cross-linking (using anti-gp60 Ab and secondary Ab) in 
EC grown on microporous ﬁlters increased transendo-
thelial 
 
125
 
I-albumin permeability without altering liquid 
permeability (hydraulic conductivity), thus, indicating 
the dissociation of hydraulic conductivity from the albu-
min permeability pathway. The ﬁndings that the sterol-
binding agent, ﬁlipin, prevented gp60-activated vesicle 
formation and that caveolin-1 and gp60 were colocal-
ized in vesicles suggest the caveolar origin of endocytic 
vesicles. Pertussis toxin pretreatment and expression of 
the dominant negative construct encoding an 11–amino 
 
acid G
 
a
 
i
 
 carboxyl-terminal peptide inhibited endothelial 
 
125
 
I-albumin endocytosis and vesicle formation induced 
by gp60 activation. Expression of dominant negative 
 
Src
 
 
(dn-
 
Src
 
) and overexpression of wild-type caveolin-1 also 
prevented gp60-activated endocytosis. Caveolin-1 over-
expression resulted in the sequestration of G
 
a
 
i
 
 with the 
caveolin-1, whereas dn-
 
Src
 
 inhibited G
 
a
 
i
 
 binding to ca-
veolin-1. Thus, vesicle formation induced by gp60 and 
migration of vesicles to the basolateral membrane re-
quires the interaction of gp60 with caveolin-1, followed 
by the activation of the downstream G
 
i
 
-coupled 
 
Src
 
 ki-
nase signaling pathway.
Key words: transcytosis • endocytosis • caveolae • 
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Introduction
 
Albumin is the primary plasma protein that maintains the
colloid osmotic pressure gradient across the semi-permeable
microvascular endothelial barrier and, hence, the plasma in-
terstitial albumin concentration gradient is critical in regulat-
ing tissue fluid balance (for review see Lum and Malik, 1994).
A transcellular pathway through endothelial cells has been
implicated in the transport of albumin (Ghitescu et al., 1986;
Milici et al., 1987; Shasby and Peterson, 1987; Michel, 1992),
lipids, hormones, peptides, and drugs that bind avidly to albu-
min (Peters, 1975; Partridge, 1979; Forker and Luxton, 1983).
 
The endothelial cell surface 60-kD glycoprotein, gp60
 
1
 
 or al-
bondin (Schnitzer et al., 1988; Ghinea et al., 1989; Schnitzer
and Oh, 1994; Tiruppathi et al., 1996), is believed to be im-
portant in the mechanism of albumin binding and activation
of transcellular albumin transport via vesicles. Albumin can
also cross the endothelial barrier via a diffusional-convective
paracellular pathway (Lum and Malik, 1994). Inflammatory
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Abbreviations used in this paper: 
 
Ab, antibody; BLMVEC, bovine lung
 
microvessel endothelial cells; cav-1, caveolin-1; DAPI, 4
 
9
 
,6-diamidino-
 
2-phenylindole, dihydrochloride; dn-
 
Src
 
, dominant negative 
 
Src
 
; EC,
endothelial cell; FM 1-43, 
 
N
 
-(3-triethylaminopropyl)-4-(p-dibutylami-
nostyryl) pyridinium dibromide; GFP, green fluorescent protein; gp60, 60-
 
kD albumin-docking protein; L
 
p
 
, hydraulic conductivity; LSM, laser
scanning microscope; RH 414, 
 
N
 
-(3-triethylammoniumpropyl)-4-(4-(4-
(diethylamino)phenyl) butadienyl)pyridinium dibromide; RT-PCR, re-
verse transcription–PCR. 
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mediators such as thrombin and histamine increase endothe-
lial albumin permeability by increasing the size of interen-
dothelial clefts (Majno et al., 1969; Garcia et al., 1986; Del
Vecchio et al., 1987; Qiao et al. 1995; Rabiet et al., 1996).
We purified gp60 from pulmonary microvascular endo-
thelial cells and showed it could bind specifically and in a
saturable manner to albumin (Tiruppathi et al., 1996). We
also showed that activation of the cell-surface gp60 using a
cross-linking antibody (Ab)
 
 
 
induced the transendothelial
flux of albumin (Tiruppathi et al., 1997). Inhibitor studies
suggested the increased albumin flux involved the activa-
tion of 
 
Src
 
 family tyrosine kinases that phosphorylated ca-
veolin-1 and gp60 (Tiruppathi et al., 1997). Formation of
vesicles induced by gp60 was inhibited by the tyrosine ki-
nase inhibitors, herbimycin A and genistein (Tiruppathi et
al., 1997; Niles and Malik, 1999). Trafficking of vesicles
to the basolateral membrane in endothelial cells also
required the 
 
N
 
-ethylmaleimide–sensitive fusion factor
(NSF) and soluble NSF attachment protein receptor
(Niles and Malik, 1999).
The heterotrimeric GTP binding protein, G
 
i
 
, binds to
caveolin-1 in the caveolar membrane (Li et al., 1995; Oka-
moto et al., 1998) and activates 
 
Src
 
 kinases (Luttrell et al.,
1996; Igishi and Gutkind, 1998; Ellis et al., 1999), which
also bind to caveolin-1 (Li et al., 1996). Since gp60 is local-
ized in the caveolar membrane (Schnitzer and Oh, 1994)
and is capable of activating 
 
Src
 
 family tyrosine kinases
(Tiruppathi et al., 1997), we addressed the possible role of
the G
 
a
 
i
 
-coupled 
 
Src
 
 kinase pathway in gp60-activated sig-
naling vesicle formation and trafficking in endothelial
cells. 
 
Materials and Methods
 
Antibodies
 
gp60 Ab was prepared as described previously (Tiruppathi et al. (1996).
Polyclonal anti-gp60 Ab was labeled with the Cy3 bisfunctional reactive
dye (Tiruppathi et al., 1997). Monoclonal and polyclonal anti–caveolin-1
antibodies were obtained from Transduction Laboratories. Rabbit-anti-
G
 
a
 
i
 
 polyclonal Ab recognizing the carboxyl-terminal region of isoforms 1
and 2 (KNNLKDCGLF) was purchased from Calbiochem. Goat anti–rab-
bit and anti–mouse IgG labeled with rhodamine, FITC, Alexa 568, or Al-
exa 488 and BSA-Alexa 488 conjugate were purchased from Kirkegaard
& Perry Laboratories and Molecular Probes, Inc. 
 
Fluorescent Probes
 
We used fluorescent water-soluble styryl pyridinium dyes 
 
N
 
-(3-trieth-
ylaminopropyl)-4-(p-dibutylaminostyryl) pyridinium dibromide (FM 1-43)
and 
 
N
 
-(3-triethylammoniumpropyl)-4-(4-(4-(diethylamino)phenyl) buta-
dienyl) pyridinium dibromide (RH 414; Molecular Probes, Inc.) to label
plasmalemma-derived vesicles (Niles and Malik, 1999). Stock solutions of
5 mg/ml were prepared in DMSO and stored in a desiccator at 
 
2
 
80
 
8
 
C for
up to 1 mo. Cell staining solutions (5 
 
m
 
g/ml) were made in HBSS contain-
ing 20 mM Hepes, 2 mM Ca
 
2
 
1
 
, and 2 mM Mg
 
2
 
1
 
. Staining solutions and
subsequent washing buffer contained fixed BSA concentration (6 mg/ml;
fraction V, 99% pure, endotoxin-free; Sigma Chemical Co.).
 
Albumin Iodination
 
BSA was labeled with Na
 
125
 
I (New England Nuclear) using the chloramine
T procedure (Bocci, 1964). Free iodine-125, separated from 
 
125
 
I-albumin
with a Sephadex G25 column, constituted 
 
,
 
0.3% of the total radioactivity.
 
Endothelial Cell (EC) Cultures
 
Bovine lung microvessel ECs (BLMVEC) were isolated and cultured in
 
high glucose DME (GIBCO BRL) supplemented with 10% FBS (Hy-
clone), 5 mM glutamine, 50 U/ml penicillin, and 50 
 
m
 
g/ml streptomycin
(Del Vecchio et al., 1992). Endothelial cell cultures were maintained in an
incubator at 37
 
8
 
C in 5% CO
 
2
 
/95% room air.
 
Plasmid DNA Preparations
 
Wild-type (wt) caveolin-1 was prepared from human umbilical vein ECs
endothelial cells by reverse transcription–PCR (RT-PCR). The sequenced
RT-PCR product was identical to human caveolin-1. The RT-PCR product
was subcloned into pcDNA3.1 (Invitrogen) and used for transfection stud-
ies. Dominant negative 
 
Src
 
 (dn-
 
Src
 
) (Y527F, K295M) and wt-
 
Src
 
 in vector
pSM were obtained from Dr. Silvio Gutkind (National Institute of Dental
Research, National Institutes of Health, Bethesda, MD). G
 
a
 
i
 
 and G
 
a
 
q
 
 dom-
inant negative minigenes encoding the 11–amino acid carboxyl terminus of
G
 
a
 
i 
 
(IKNNLKDCGLF) or G
 
a
 
q
 
 (LQLNLKEYNAV; Gilchrist et al., 1998)
were ligated into pcDNA3.1 plasmid vector. A minigene encoding a scram-
bled sequence of G
 
a
 
i
 
 (NGIKCLSNDKL) was used as a negative control.
Green fluorescent protein (GFP) plasmid DNA (plasmid pGREEN LAN-
TERN-1) was purchased from GIBCO BRL. 
 
125
 
I-Albumin Endocytosis
 
Endocytosis of 
 
125
 
I-albumin was measured as described previously (Tirup-
pathi et al., 1997). BLMVEC were grown to confluence in either 6- or 12-
well culture plates. Monolayers were washed twice with 10 mM Hepes-buff-
ered DME, pH 7.4, and the uptake of 
 
125
 
I-albumin was carried out for 25 min
at 37
 
8
 
C. Endocytosis was terminated by placing EC monolayers on ice and
washing three times with either pH 2.5 buffer (0.2 M acetic acid and 0.5 M
NaCl) or pH 3.0 buffer (20 mM glycine-HCl and 0.15 M NaCl) to remove the
surface-bound 
 
125
 
I-albumin (Tiruppathi et al., 1992). Cells were lysed with 50
mM Tris-HCl buffer, pH 7.4, containing 1% Triton X-100 and 0.5% SDS,
and the lysate was used to measure endocytosis of 
 
125
 
I-albumin.
 
Transendothelial 
 
125
 
I-Albumin Permeability
 
Transendothelial 
 
125
 
I-BSA permeability of BLMVEC monolayers grown
on microporous polycarbonate transwell filter inserts (Corning Costar
Corp.) was measured as previously described (Del Vecchio et al., 1987;
Siflinger-Birnboim et al., 1988).
 
Endothelial Monolayer Hydraulic Conductivity (L
 
p
 
)
 
Confluent BLMVEC on gelatin-coated microporous polycarbonate filters
were used to measure transendothelial fluid flux using the two-compart-
ment system (Qiao et al., 1993). Both upper and lower chambers were
filled with 0.5% albumin in HBSS, pH 7.4, at 37
 
8
 
C and sealed with rubber
stoppers. Constant flow perfusion was used to renew the luminal fluid ev-
ery minute and to prevent an increase in osmolarity. Hydrostatic pressure
in the upper chamber was controlled by adjusting the height of the out-
flow tubing. The filtrate was collected in 1-min intervals and the filtration
rate per unit surface (Jv [
 
3
 
10
 
-6
 
 ml/cm
 
2
 
/s]) was calculated by measuring the
timed movement of fluid meniscus in the collecting tubing. The filtration
rate at the two given pressures (P
 
1
 
 
 
5 
 
0 cm H
 
2
 
O and P
 
2
 
 5 
 
5 cm H
 
2
 
O) at 20-
min intervals was measured for up to 2 h. The L
 
p 
 
was calculated as
 (Qiao et al., 1993).
 
Cell-surface gp60 Cross-linking
 
BLMVEC monolayers were washed twice with Hepes-buffered DME (at
4
 
8
 
C) and incubated with 10 
 
m
 
g/ml of anti-gp60 Ab, followed by 10 
 
m
 
g/ml of a
secondary Ab (goat anti–rabbit) for 30 min at 4
 
8
 
C (Tiruppathi et al., 1997).
After treatment, the cells were rewarmed to 37
 
8
 
C for the experiments.
 
Styryl Pyridinium Dye Uptake
 
Endocytosis in endothelial cells was quantified as described previously
(Niles and Malik, 1999) using the styryl pyridinium dyes, FM 1-43 and RH
414. In brief, 5 
 
3 
 
10
 
4
 
 BLMVEC were plated on 25-mm-diam No. 1 cover-
slips or Lab-tek chamber slides (Nalge Nunc Intl.) coated with 0.1% gela-
tin. Cells were incubated in buffered medium containing 5 
 
m
 
g/ml FM 1-43
or RH 414 at 37
 
8
 
C for 15 min, and then washed three times in ice-cold
HBSS. As styryl pyridinium dyes fluoresce brightly at the membrane–
water interface (Betz et al., 1992), FM 1-43 fluorescence associated with
the cells after washing cell surface probe was the result of incorporation of
FM 1-43 into plasmalemma-derived vesicles.
Jv1 Jv2 – () P1 P2 – () ¤ 
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Digital Fluorescent Microscopy
 
Live cell fluorescent imaging was performed with an inverted Nikon mi-
croscope as previously described (Niles and Malik, 1999). Fluorescence
and differential interference contrast images were recorded for each cell
field with a cooled integrating charge-coupled device camera (Imagepoint;
Photometrics). Quantitative analysis of images (median cell brightness and
the number of particles per cell) was performed using Image Pro Plus soft-
ware with custom written functions as previously described (Niles and
Malik, 1999). Data expressed as median cell brightness or number of par-
ticles per cell were consistent within each treatment. 
 
Colocalization of gp60 and FM 1-43
 
Confluent BLMVEC on coverslips were incubated for 15 min at 37
 
8
 
C in a
mixture of 5 
 
m
 
g/ml FM 1-43 and 5 
 
m
 
g/ml Cy3-conjugated anti-gp60 Ab in
HBSS plus 10 mg/ml BSA to colabel cytosolic vesicles. Cells were washed
quickly three times with ice-cold HBSS containing 10 mg/ml albumin to re-
move external FM 1-43 and three times for 5 min each with ice-cold pH 5.0
buffer (0.1 M NaCl plus 0.05 M sodium acetate) to remove Cy3-labeled
anti-gp60 Ab attached to cell-surface gp60. The cells were warmed to 37
 
8
 
C
for 5 or 45 min to allow the colabeled vesicles to migrate. Cells were viewed
by laser scanning confocal microscopy (laser scanning microscope [LSM] 410
and 510; Carl Zeiss) in sequential optical sections. The section plane was ad-
vanced in 0.1-
 
m
 
m increments through the cell from the apical to the basolat-
eral side. At each optical plane, the specimen was scanned at 488 nm to ex-
cite FM 1-43 and then at 568 nm to excite Cy3 (argon/krypton laser). FM 1-43
(green) and Cy3 (red) images were overlaid and analyzed for coincident red
and green pixels (thus the colocalized fluorescence was in yellow).
 
Localization of gp60, G
 
a
 
i
 
, and Caveolin-1
 
Cellular localization of G
 
a
 
i
 
, gp60, and caveolin-1 in the plasma membrane
Figure 1. Labeling of gp60
and endocytic vesicles in live
endothelial cells. (a) BLM-
VEC were incubated with Cy3-
labeled anti-gp60 Ab at 378C
for 15 min and washed at a
low temperature (48C) to la-
bel gp60; red fluorescent im-
ages reflect cell surface and
internalized fluorescence.
(b) Cells were treated iden-
tically to a, except that cells
were washed with a low pH
(3.0) fluid to show internal-
ized gp60. (c) Control pho-
tomicrograph only shows
background staining when in-
cubation was carried out at
48C and washed with pH 3.0
buffer. (d) Cells were incu-
bated for 15 min at 378C with
FM 1-43 and washed at nor-
mal pH with dye-free buffer
to label endosomes; green flu-
orescence indicates FM 1-43
incorporated in endosomes during the incubation period. (e) 15-min incubation
with FM 1-43 at 48C (to inhibit endocytosis) prevents fluorescent dye internal-
ization. Other details are described in Materials and Methods. Identical results
were observed with the chemically similar styryl dye, RH 414 (as shown in Fig. 8
and Fig. 9); thus, FM 1-43 and RH 414 dyes were used interchangeably to label
endocytic vesicles. Results are representative of five experiments. Bar, 20 mm.
 
and plasmalemmal vesicles of endothelial cells exposed to albumin or gp60
cross-linking (described above) was determined by immunocytochemical
labeling and laser scanning confocal microscopy (Zeiss LSM 210 and 510).
BLMVEC were serum-deprived for 24 h, washed three times with Hepes-
buffered HBSS or phenol red-free DME, and exposed to 6 mg/ml BSA in
the presence or absence of 50 
 
m
 
g/ml Alexa 488–conjugated BSA and/or
3.5 
 
m
 
g/ml cy3-anti-gp60 Ab for up to 30 min. Cells were either washed
three times with HBSS and imaged live, or fixed with 4% paraformalde-
hyde in HBSS and blocked for 30 min in HBSS containing 5% goat serum,
0.1% Triton X-100, and 0.01% NaN
 
3
 
. Primary Ab labeling was performed
overnight at 4
 
8
 
C with anti–caveolin-1 mAb (1 
 
m
 
g/ml), polyclonal anti-G
 
a
 
i
 
Ab (1:100 dilution), or 20 
 
m
 
g/ml anti-gp60 IgG. Coverslips were washed
three times for 10 min in HBSS, blocked for 30 min with 5% goat serum,
and incubated for 2 h at room temperature with fluorescently labeled goat
anti–rabbit and goat anti–mouse Ab. In some cases, 4
 
9
 
,6-diamidino-2-phe-
nylindole, dihydrochloride (DAPI; 1 
 
m
 
g/ml) was added to visualize the nu-
cleus. Confocal microscopy was performed using 364-, 488-, and 568-nm
excitation laser lines to detect DAPI (BP385-470 nm emission), FITC/Al-
exa 488 (BP505-550 emission), and rhodamine/Alexa 568 fluorescence
(LP585 emission) in optical sections 
 
,
 
1 
 
m
 
m in thickness (pinhole set to
achieve 1 Airy unit). 
 
Pertussis Toxin Treatment
 
Confluent BLMVEC were incubated in DME containing 100 ng/ml per-
tussis toxin for 6 h at 378C. Control cells were incubated in toxin-free me-
dium for 6 h before labeling with the styryl dye.
Filipin Treatment
Confluent BLMVEC were serum-deprived for 24 h and pretreated with
50 nM filipin (25 ng/ml) for 30 min at 378C. Control cells were incubated
with serum- and phenol red–free DME containing vehicle DMSO
(0.005% DMSO).
Plasmid Transfection Studies
Expression of Gai minigene, wt-caveolin-1, and dn-Src. BLMVEC were
grown to 50% confluence in 60-mm-diam plates and transfected using Ef-The Journal of Cell Biology, Volume 150, 2000 1060
fectene (QIAGEN Inc.) according to manufacturer’s protocol. Plasmid
DNA–Effectene complexes containing either 0.25 mg/ml vector alone, wt-
caveolin-1, wt-Src, dn-Src, dn-PKCa, or Gai-, Gaq-, or Ga-random se-
quence minigene constructs were incubated with 0.25 mg/ml GFP (GIBCO
BRL) in DME containing 10% FBS. The transfection mixture was re-
moved after 6 h and fresh media containing 10% FBS was applied. At 24 h
after transfection, cells were trypsinized and transferred to either multi-
well Lab-tek chambers for styryl pyridinium dye uptake studies, to 35-
mm-diam wells for obtaining cell lysates, or to 12 mm-diam No. 1 glass
coverslips for immunostaining. Cells were allowed to grow for an addi-
tional 24 h, and then used for experiments (48 h after transfection). Trans-
fection efficiency was .30%.
Coimmunoprecipitation of Caveolin-1 and gp60
Confluent BLMVEC in 60-mm-diam culture dishes were kept in serum-
free medium overnight and metabolically labeled with 200 mCi/ml 32P-
orthophosphate for 4 h. Cells were stimulated for 20 min with 6 mg/ml
BSA and lysed (30 min at 48C in 50 mM Tris-HCl, pH 7.5, containing 150
mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1.0% NP-40, 0.1%
SDS, 1 mM Na3VO4, 1 mM NaF, 2 mg/ml leupeptin, 2 mg/ml pepstatin A,
2 mg/ml aprotinin, and 44 mg/ml PMSF). Insoluble material was removed
by centrifugation (13,000 g for 15 min) before overnight immunoprecipita-
tion with preimmune IgG (10 mg/ml), anti-gp60 Ab (10 mg/ml), or poly-
clonal anti–caveolin-1 Ab (1 mg/ml) at 48C. Protein A or G agarose beads
were added to each sample and incubated for 1 h at 48C. Immunoprecipi-
Figure 2. Activation of gp60 using cross-linking Ab increases
vesicle formation in endothelial cells. BPMVEC were incubated
with either anti-gp60 Ab (plus secondary Ab) or control Ab (pre-
immune IgG; 5 mg/ml) for 30 min at 48C. Cells were incubated at
378C for 15 min with 5 mg/ml FM 1-43 plus 10 mg/ml BSA. Me-
dian brightness values of cells and the number of fluorescent par-
ticles per cell were determined after three washes with buffer.
The asterisk indicates increased particle density and median cell
brightness (P , 0.05) from corresponding control values.
Figure 3. Colocalization and
migration of gp60 and plas-
malemma-derived vesicles.
(a) Cy3-labeled anti-gp60 Ab
was used to fluorescently tag
gp60 in BLMVEC incubated
in 10 mg/ml BSA. Endo-
somes were labeled at the
same time with 5 mg/ml FM
1-43 to show colocalization
of vesicles with gp60. After
coincubation with both
probes for the indicated
times, cell-surface fluores-
cence was removed by exten-
sive rinsing with pH 5.0
buffer at 48C. Top row shows
confocal images (633 objec-
tive), near the luminal cell
surface, of early (5 min) in-
tracellular fluorescence be-
cause of vesicle marker FM
1-43 (green, left), cy3-labeled
anti-gp60 Ab (red, middle), and colocalization image (yellow,
right). Bottom row shows albumin cell surface after exocytosis.
Note the relative absence of colocalization at 45 min. (b) Plot of
migration of gp60-containing vesicles in an endothelial cell. Plot
gives relative colocalized fluorescence intensity versus depth of
the optical section through the endothelial cell. Peak fluorescent
intensity occurred near the luminal cell surface at 5 min after co-
labeling, whereas the peak is shifted towards the basolateral sur-
face at 45 min. The peak colocalized fluorescence intensity de-
creased at 45 min compared with 5 min because of exocytosis of
FM 1-43 and dilution of its fluorescence in extracellular fluid.
Results are representative of five experiments.Minshall et al. Gp60-activated Endothelial Permeability 1061
washes, membranes were incubated at 228C with HRP-conjugated goat
anti–rabbit Ab. After incubation, membranes were washed twice, and
protein bands were localized by incubating with enhanced chemilumines-
cence reagent (Pierce Chemical Co.).
Statistical Analysis
Statistical comparisons were made using the t test with the significance
level set at P , 0.05.
Results
Activation of gp60 Induces Plasmalemmal
Vesicle Formation
The cellular distribution of gp60 was determined after in-
cubating confluent endothelial cells for 30 min with Cy3-
conjugated anti-gp60 Ab. We observed punctate distribu-
tion of fluorescence after incubation of the probe at 378C,
followed by cold (48C) wash buffer to remove the cell sur-
face–bound Cy3 probe (Fig. 1 a). To visualize internalized
gp60, cell-surface fluorescence was removed by an acid
wash. The resultant image showed that gp60 was internal-
ized during the incubation period (Fig. 1 b). Reduction of
the temperature to 48C followed by a low pH wash pre-
vented the gp60 internalization (Fig. 1 c).
Endothelial cell monolayers were incubated with styryl
pyridinium dye, FM 1-43 (5 mg/ml), for 15 min at 378C,
and then rinsed with dye-free buffer to visualize plasma-
lemma-derived endocytic vesicles. Endothelial cells incu-
bated in FM 1-43 exhibited the punctate distribution of
fluorescence characteristic of vesicles (Fig. 1 d). Vesicle
formation was inhibited when cells were kept at 48C dur-
ing the dye loading period (Fig. 1 e).
To determine the effects of gp60 cross-linking on vesicle
formation, BLMVEC were incubated with either anti-
gp60 Ab or preimmune IgG (control Ab) for 30 min at 48C
followed by anti-rabbit secondary Ab for 30 min at 48C.
Cells were exposed to FM 1-43 for 15 min at 378C, mem-
brane-bound dye was washed, and intracellular FM 1-43
fluorescence was quantified as median brightness of cells
and the number of fluorescent particles per cell. The gp60
cross-linking produced 2.0–3.8-fold increases in cell fluo-
rescence by either measure compared with controls (Fig. 2).
Activation of gp60 Induces Transcellular Migration of 
Plasmalemma-derived Vesicles
To determine the fate of gp60 and of vesicles formed by
gp60 activation, FM 1-43–labeled vesicles were colocalized
with the Cy3-conjugated anti-gp60 Ab. Cells were washed
with acid buffer to detach Cy3-anti-gp60 Ab from the cell
surface before imaging. Confocal images of each fluores-
cent probe were obtained at 0.1-mm z-axis step increments
from the apical to basolateral cell membrane. Colocaliza-
tion was determined by merging red (Cy3 fluorescence)
and green images (Fig. 3 a; FM 1-43 fluorescence). Al-
though FM 1-43 labels all plasmalemmal-derived vesicles,
a fraction of these vesicles were colocalized (yellow) with
the fluorescently labeled gp60 Ab.
To follow the migration of plasmalemma-derived vesi-
cles, endothelial cells were colabeled with fluorescent anti-
gp60 Ab and FM 1-43 for 15 min at 378C, washed (48C), and
rewarmed (378C) for either 5 or 45 min to activate the ves-
Figure 4. Gp60 activation increases transendothelial flux of 125I-
albumin without increasing barrier hydraulic conductivity. (a)
BLMVEC monolayers on filters were washed twice with Hepes-
DME and incubated with either anti-gp60 Ab or preimmune (PI)
IgG (10 mg/ml) for 30 min at 228C, followed by treatment with 10
mg/ml goat anti–rabbit secondary Ab for 30 min. Monolayers
were used for transendothelial 125I-albumin permeability mea-
surements at 378C. Both luminal and albuminal compartments
contained 30 mg/ml of unlabeled albumin. Asterisk indicates the
difference from control (P , 0.001). (b) Lack of effect of gp60
cross-linking on endothelial monolayer hydraulic conductivity
(Lp). A system consisting of BLMVEC cultured on filters using
the two compartment system was used to measure Lp (Qiao et al.,
1993); medium albumin concentration was 5 mg/ml. Monolayers
were washed and incubated with either anti-gp60 Ab (to induce
gp60 cross-linking) or preimmune IgG (10 mg/ml) for 10 min,
followed by secondary Ab treatment for 5 min. Values are the
mean 6 SEM (n 5 5).
tates were gently washed three times with 150 mM Tris-HCl buffer con-
taining 0.05% Triton X-100, 1 mM Na3VO4, 1 mM NaF, 2 mg/ml leupeptin,
2 mg/ml pepstatin A, 2 mg/ml aprotinin, and 44 mg/ml PMSF. Immunopre-
cipitated proteins were resolved on SDS-PAGE, transferred to Duralose
membrane, and visualized by autoradiography. Protein bands were identi-
fied by reprobing with either anti-gp60 Ab or anti–caveolin-1 Ab.
Western Blot Analysis
BLMVEC lysates (10 mg protein was loaded per lane) were resolved by
SDS-PAGE on a 12% separating gel under reducing conditions and trans-
ferred to Duralose membrane. Membranes were blocked with (5% dry
milk in 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) for 2 h
at 228C. Membranes were incubated with a 1:3,000 dilution of polyclonal
anti–caveolin-1 Ab or 0.4 mg/ml anti-Gai or Gaq Ab at 228C for 3 h. AfterThe Journal of Cell Biology, Volume 150, 2000 1062
icle migration. At 5 min after colabeling, the vesicles
that formed during the dye incubation period were lo-
cated in the cytosol near the apical plasmalemma; i.e., in
upper one-third of each cell (Fig. 3 a, top row). At 45
min after colabeling, the vesicles containing gp60 and
endocytic marker dye had migrated to the lower half of
the cell near the basolateral plasmalemma (Fig. 3 a, bot-
tom row).
Fig. 3 b shows the colocalization of fluorescence in dif-
ferent optical section depths of the cell at either 5 or 45
min after gp60 activation. At 5 min after gp60 activation,
the peak colocalized fluorescence (i.e., the gp60-activated
vesicles) was observed ,0.5 mm from the apical surface.
At 45 min, the peak colocalized fluorescence was shifted
toward the basolateral cell surface (i.e., at a section depth
of 1.5 mm). Because of the release of styryl dye into the ba-
solateral extracellular compartment, the immunofluores-
cence intensity of the 45-min peak was markedly dimin-
ished, such that residual immunofluorescence primarily
reflected the persistence of gp60 antigen in the basolateral
aspect of the cell.
Effects of gp60 Activation on Transendothelial
125I-Albumin Flux and Endothelial
Hydraulic Conductivity
We measured transendothelial flux of tracer 125I-albumin
and hydraulic conductivity in confluent BLMVEC mono-
layers grown on polycarbonate filters to determine gp60-
activated transendothelial albumin permeability and its
relationship to liquid permeability. Cross-linking of gp60
at 378C using 10 mg/ml anti-gp60 Ab plus secondary Ab
increased transendothelial 125I-albumin permeability by
twofold (Fig. 4 a). However, the increased 125I-albumin per-
meability was dissociated from endothelial monolayer hy-
draulic conductivity (Lp; Fig. 4 b). As gp60 activation in-
creased transendothelial albumin permeability without
increasing water permeability, the results indicate in-
creased albumin flux through transcellular pathways.
Colocalization of gp60 and Albumin in
Plasmalemma-derived Vesicles
To determine the pattern of localization of gp60 and albu-
Figure 5. Colocalization of gp60 with albumin.
Confocal images of BLMVEC grown to conflu-
ence on gelatin-coated glass coverslips showing
fluorescent staining of gp60, DAPI, and Alexa
488-albumin. (a) Single section (,1.0 mm thick;
four frame average) near the apical membrane
surface showing gp60 (red), DAPI (blue), albumin
(green), and the overlay of gp60, albumin, and
DAPI immunostaining in BLMVEC. (b) Merged
images of gp60, DAPI, and albumin in confocal
z-axis optical sections (0.2-mm step size; two
frame averages) through a single BLMVEC. Pro-
jection image (22 sections stacked) en face (b)
show the distribution of gp60 and albumin in the
cell.Minshall et al. Gp60-activated Endothelial Permeability 1063
min after activation of gp60, we evaluated immunostaining
of cells after a 30 min incubation (378C) with Cy3-anti-gp60
Ab and Alexa 488 BSA in phenol red–free DME contain-
ing 5 mg/ml albumin. Fig. 5 a shows the punctate fluores-
cent structures containing gp60 Ab (red), DAPI staining
of the nucleus (blue), and fluorescently labeled albumin
(green) near the apical membrane of BLMVEC. An over-
lay image (Fig. 5 a, far right) of the three probes shows a
high degree of gp60 and albumin colocalization (in yel-
low). A projection image of BLMVEC gp60, DAPI, and
Figure 6. Coimmunoprecipitation and migration of caveolin-1 and gp60. BLMVEC were grown to confluence, serum-deprived over-
night, and metabolically labeled for 4 h with 200 mCi/ml 32P-orthophosphate. Cells were either stimulated for 20 min with 6 mg/ml BSA
(b) or not stimulated with BSA (a) and lysed. Total cell lysate was immunoprecipitated with preimmune rabbit IgG (lanes 1 and 4), rab-
bit anti-gp60 IgG (lanes 2 and 5), or rabbit anti–caveolin-1 IgG (lanes 3 and 6), separated by SDS-PAGE, transferred to a nitrocellulose
membrane, and visualized by autoradiography. As shown in lane 4 (b), the cell lysate that immunoprecipitated with the anti-gp60 Ab
also contained a 22-kD protein, which migrated similarly to that immunoprecipitated with anti–caveolin-1 Ab (b, lane 6). (b) Lane 6
shows that the cell lysate that immunoprecipitated with anti–caveolin-1 Ab also pulled down a protein similar to that immunoprecipi-
tated with the anti-gp60 Ab (b, lane 5). Control Ab did not immunoprecipitate either 32P-labeled protein. In the absence of albumin
stimulation, gp60 was not coimmunoprecipitated with the anti–caveolin-1 Ab (a, lane 2 and 3). Results are representative of three ex-
periments. (c–e) Merged images of gp60 (red) and caveolin-1 (green) immunostaining of BLMVEC monolayers after albumin exposure
for 0 (c), 3 (d), or 30 min (e). Gp60 and caveolin-1 staining appeared near the apical surface in the absence of added albumin (c, top
panel). With the addition of albumin, gp60 migrated towards the basolateral aspect of the cell monolayer (d, at 3 min, middle panel, and
e, at 30 min, bottom panel of images). The green fluorescence did not redistribute with time to the same extent as gp60. (f and g) Effects
of filipin on fluorescent albumin uptake. BLMVEC were pretreated with vehicle (f, control) or 50 nM filipin (g) for 30 min at 378C,
and then incubated with medium containing 5 mg/ml BSA and 50 mg/ml Alexa 488 albumin for 30 min at 378C. The cells were washed
and imaged for albumin internalization. Results are representative of five experiments. Bar, 20 mm.The Journal of Cell Biology, Volume 150, 2000 1064
Figure 7. Role of Gi signal-
ing in gp60-induced vesicle
formation. (a) Cell-surface
Gai immunostaining de-
creases after gp60 activation.
BLMVEC exposed to vehi-
cle (left) or anti-gp60 Ab
(right) for 10 min at 378C
were labeled with polyclonal
anti-Gai Ab plus Alexa 488–
conjugated goat anti–rabbit
secondary Ab. Confocal im-
ages (eight frame average,
,1.0-mm thick optical sec-
tions near the apical plasma
membrane) were acquired
with a Zeiss LSM 210. (b)
Pertussis toxin inhibits gp60-
activated  vesicle formation.
BLMVEC were preincu-
bated for 6 h at 378C in me-
dium containing 100 ng/ml
pertussis toxin. At end of the
preincubation period, en-
docytosis was stimulated by
30 min of incubation in 5 mg/
ml anti-gp60 Ab to cross-link
gp60. FM 1-43 (5 mg/ml) was
added to cells during the fi-
nal 15 min of Ab incubation;
excess styryl dye was washed
away with three changes of
ice-cold buffer. Control cells
received no toxin during 6-h
preincubation period. Me-
dian cellular fluorescence in-
tensity is shown. Pertussis
toxin blocked FM 1-43 en-
docytic marker dye uptake
that was induced by the acti-
vation of gp60 with anti-gp60
Ab (gp60 cross-linking). The
asterisk indicates an increase
(P , 0.05) of median fluores-
cence intensity because of
gp60 cross-linking (in the ab-
sence of pertussis toxin). (b,
inset) Fluorescent images of
cells: (left) no pertussis
toxin; (right) pertussis toxin
treatment. Results are rep-
resentative of three experi-
ments. (c) Pertussis toxin
(100 ng/ml for 6 h) inhibits
125I-albumin uptake in endo-
thelial cells induced by gp60
cross-linking. Cells were in-
cubated in 125I-labeled tracer
albumin for 25 min after
gp60 cross-linking, washed
three times in pH 2.5 buffer,
lysed, and counted for 125I-
labeled albumin. Bars indi-
cate SD (n 5 3). The single
asterisk indicates a differ-
ence from no anti-gp60 Ab
(2) control group (P , 0.05);
and the double asterisk indi-
cates a decrease relative to
the anti-gp60 Ab–activatedMinshall et al. Gp60-activated Endothelial Permeability 1065
(1) group (P , 0.05). (d and e) Expression of Gai carboxyl-terminal peptide in endothelial cells inhibits gp60-activated endocytosis. (d)
BLMVEC were cotransfected with GFP in pcDNA3.1 and a pcDNA3.1 expression vector containing the minigene construct encoding
an 11–amino acid carboxyl-terminal sequence of the guanine nucleotide binding protein Gai (dn-Gai), Gaq, (dn-Gaq), or a randomized
sequence (Ga-scr). The cells were serum-deprived for 24 h and incubated for 15 min with 6 mg/ml BSA and 5 mg/ml RH 414. Images of
RH 414 dye uptake were acquired in transfected cells (GFP-positive) by confocal microscopy. (e) Summary of RH 414 fluorescence in-
tensity in G-protein minigene–transfected cells. Expression of Gai-carboxyl-terminal peptide inhibited gp60-activated endocytosis in
BLMVEC, whereas BLMVEC expressing Gaq peptide or Ga-randomized sequence peptide showed the characteristic endocytic re-
sponse secondary to gp60 activation. The asterisk indicates decrease from corresponding control values (cells transfected with dn-Gaq or
Ga-randomized sequence peptide; P , 0.05). Bar: (a) 10 mm; (b) 2 mm.
albumin fluorescent staining is shown in Fig. 5 b. The en
face (x-y) view of stacked z-plane images (22 sections)
showed marked colocalization of gp60 Ab and albumin in
the same endocytic vesicles (Fig. 5 b).
Gp60 and Caveolin-1 Interaction
We metabolically labeled serum-deprived BLMVEC with
32P-orthophosphate for 4 h, stimulated with or without 6
mg/ml albumin for 20 min, and prepared the cell lysates
for immunoprecipitation to study caveolin-1 and gp60 in-
teractions (see Materials and Methods). Incubation of the
cell lysate with control Ab failed to precipitate either gp60
or caveolin-1 (Fig. 6, a and b, lanes 1 and 4). In the absence
of albumin, anti-gp60 Ab or anti–caveolin-1 Ab immuno-
precipitates revealed 60- and 22-kD proteins (Fig. 6 a, lane
2 and 3), which corresponded to gp60 and caveolin-1, re-
spectively. However, in the case of albumin stimulation,
anti-gp60 Ab immunoprecipitated 60-, 36-, and 22-kD pro-
teins (Fig. 6 b, lane 5). The 60- and 22-kD bands were
identified as gp60 and caveolin-1, respectively, by Western
blotting (not shown). The 36-kD band may be CD36, the low
density lipoprotein receptor (Huang et al., 1991; Lisanti
et al., 1994; Tiruppathi et al., 1997). In addition, anti–cave-
olin-1 Ab precipitated caveolin-1 as well as gp60 in the al-
bumin-stimulated cells (Fig. 6 b, lane 6). Thus, the physical
association of gp60 with caveolin-1 in endothelial cells is
facilitated by the activation of gp60 with albumin.
Serum-deprived BLMVEC were stimulated with albu-
min for 0, 3, or 30 min, and were fixed and stained with anti-
gp60 and caveolin-1 Abs to address whether gp60 and ca-
veolin-1 immunostaining comigrated from the apical to
basolateral surfaces as a function of albumin exposure. In
the absence of albumin, gp60 (red) and caveolin-1 (green)
immunostaining, which showed a marked overlap (in yel-
low), appeared near the apical surface of BLMVEC mono-
layers (Fig. 6 c), as seen in the z-axis optical sections (top left,
apical surface; bottom right, basolateral surface). Exposing
cells to 6 mg/ml BSA for 3 min (Fig. 6 d) or 30 min (Fig. 6 e)
to activate gp60 induced the internalization and basolateral
migration of gp60. The green fluorescence, which marked
caveolin-1, did not redistribute towards the basolateral
membrane to the same extent as gp60. In control experi-
ments, nonspecific immunofluorescence observed in the
presence of preimmune rabbit IgG, control mouse IgG, or
with secondary antibodies alone was minimal; it did not
show a pattern of colocalization and also did not change af-
ter the exposure of endothelial cell monolayers to albumin.
BLMVEC were treated with filipin to determine whether
disruption of caveolae influenced albumin uptake induced
by gp60. BLMVEC were incubated in the presence or ab-
sence of 50 nM filipin for 30 min at 378C and incubated
with anti-gp60 Ab for 30 min at 48C to cross-link gp60.
Cells were incubated with Alexa 488-BSA for 30 min in
media containing 5 mg/ml of unlabeled BSA and acid-
washed to remove extracellular label. As shown in Fig. 6 g,
filipin prevented the formation of vesicles as compared
with control cells (Fig. 6 f).
Gi Transduces gp60-activated Vesicle Formation
We used three approaches to address the role of Gi in the
mechanism of gp60-induced vesicle formation and traffick-
ing: (1) pertussis toxin, which prevents activation of Gi/G0
by ADP ribosylation (Hepler and Gilman, 1992); (2) trans-
fection of the dn construct encoding the 11–amino acid
carboxyl-terminal peptide sequence of Gai1/2,which com-
petes for Gai–receptor interactions (Gilchrist et al., 1998);
and (3) Gai immunostaining.
In control BLMVEC, Gai was localized in the apical
membrane (Fig. 7 a, left). Cross-linking of gp60 for 10 min
resulted in a decreased apical membrane–associated Gai
immunostaining (Fig. 7 a, right). Pretreatment of endothe-
lial monolayers with the pertussis toxin prevented both
FM 1-43 and 125I-albumin endocytosis induced by gp60
(Fig. 7, b and c). In addition, the expression of Gai car-
boxyl-terminal peptide (dn-Gai) in BLMVEC also pre-
vented the gp60-activated vesicle formation as determined
by RH 414 uptake in green fluorescent protein (GFP)–
positive endothelial cells (Fig. 7, d and e). In control ex-
periments, endothelial cells transfected with the Gaq mini-
gene (dn-Gaq) or control minigene encoding a randomized
sequence of Gai carboxyl terminus (Ga-scr; Fig. 7, d and e)
showed the characteristic activation of endocytosis sec-
ondary to gp60 stimulation.
Expression of Caveolin-1 and dn-Src Inhibit
Vesicle Formation
We studied the effects of overexpression of wt-caveolin-1
since caveolin-1 can bind to Gai (Li et al., 1995) and, thus,
may functionally inactivate endogenous Gai. Since caveo-
lin-1 and gp60 are phosphorylated by Src family kinases
after gp60 activation (Tiruppathi et al., 1997), we also
studied the role of Src by inducing the expression of dn-
Src. Whole cell lysates from BLMVEC transfected with
vector alone (Mock), wt-caveolin-1 (wt-Cav-1), or dn-Src
were immunoprecipitated with anti–caveolin-1 Ab, sepa-
rated by SDS-PAGE, and blotted with Abs against caveo-
lin-1, Gai, and Gaq (Fig. 8). The resulting blots showed a
twofold increase in expression of caveolin-1 in cells trans-
fected with wt-caveolin-1 (lane 2) compared with mock-The Journal of Cell Biology, Volume 150, 2000 1066
transfected cells (lane 1). Caveolin-1 overexpression aug-
mented the association of caveolin-1 with both Gai and
Gaq (lane 2), indicating the sequestration of G-proteins
with the expressed caveolin-1. Expression of dn-Src de-
creased the amount of caveolin-1 (Fig. 8, lane 3, top) and
abolished association of caveolin-1 with Gai (Fig. 8, lane 3,
middle), whereas it had no effect on caveolin-1 association
with Gaq (Fig. 8, lane 3, bottom panel). Thus, the dissocia-
tion of Gai from caveolin-1 induced by dn-Src suggests an
important role of Src in regulating the integrity of the ca-
veolin-1/Gai signaling complex.
To determine the effects of caveolin-1 overexpression
and dn-Src expression on gp60-activated vesicle forma-
tion, GFP was co-expressed with wt-caveolin-1 or dn-Src
in BLMVEC, and styryl dye uptake was measured in the
GFP-positive cells. Images of GFP-positive cells in the
left panels (Fig. 9, a, c, and e) are shown with images of
the same field of RH 414 uptake in the right panels (Fig.
9, b, d, and f). In cells expressing the empty vector (Fig. 9
a), we observed gp60-activated RH 414 dye uptake (Fig.
9 b). However, overexpression of wt-caveolin-1 (Fig. 9 c)
or expression of dn-Src (Fig. 9 e) prevented vesicle for-
mation (Fig. 9, d and f) in the GFP-positive cells, but not
in the nontransfected cells (ntf). As a control for dn-Src,
wt-Src and dn-PKCa were co-expressed with GFP in
BLMVEC. In these control experiments, we observed
the characteristic activation of endocytosis secondary to
gp60 activation (Fig. 9, g–h). Thus, the results show that
caveolin-1 overexpression and dn-Src expression abol-
ished gp60-activated vesicle formation in endothelial
cells.
Discussion
Serum albumin is critical for the maintenance of the nor-
mal oncotic pressure gradient across microvessels and for
stability of the endothelial barrier (Michel and Curry, 1999).
The endothelial cell monolayer has the capacity to regu-
late the directed movement of albumin between its lumi-
nal and albumin membrane surface. Transcytosis involves
albumin uptake from the vascular space by endocytosis,
the vectorial transfer of vesicles from the apical to the ba-
solateral membrane, and the release of albumin by exocy-
tosis into the subendothelial space. Transcytosis may be
physiologically important in regulating the transendothe-
lial albumin concentration gradient and transport of albu-
min-bound ligands such as hormones, nonesterified fatty
acids, and ions.
The endothelial cell-surface glycoprotein gp60, an albu-
min-binding protein, has been invoked in the mechanism
of albumin transcytosis (Schnitzer et al., 1988; Ghinea et al.,
1989; Schnitzer, 1992; Schnitzer and Oh, 1994; Tiruppathi
et al., 1996, 1997). The present study provides new infor-
mation on the signal transduction pathways activated by gp60
that induce the formation of vesicles and the targeted mi-
gration of vesicles to the basolateral membrane. We showed
that upon gp60 activation, gp60 becomes colocalized with
albumin and it interacts with caveolin-1. Albumin, the
gp60 ligand, did not induce the formation of plasmalem-
mal-derived vesicles in brain microvessel endothelial cells
that lacked gp60 (Minshall et al., data not shown). Vesicle
formation, which was activated by gp60, required the het-
erotrimeric G protein Gi, since treatment of cells with per-
tussis toxin and expression of an antagonist peptide, which
uncouples Gai from its receptor binding site (Gilchrist et al.,
1998), prevented the budding of vesicles and albumin en-
docytosis. Overexpression of wt-caveolin-1, which was shown
to sequester Gai, and expression of dn-Src also prevented
the gp60-induced vesicle formation by interfering with the
Gi signaling pathway.
The present study demonstrates an important role of
gp60 in stimulating endocytosis and the directed migration
of vesicles in endothelial cells. Analysis of serial confocal
sections showed the apical-to-basolateral migration of ves-
icles activated by gp60 in live endothelial cells, which is
suggestive of a transcytotic process. We showed that vesic-
ular markers (FM 1-43 and RH 414) were taken up in the
apical membrane–derived, gp60-positive vesicles, and that
the destaining of vesicular markers occurred at the baso-
lateral endothelial cell surface. Interestingly, gp60 re-
mained localized in the basolateral vesicles after the re-
lease of styryl dye, suggesting that gp60 has the potential
to recycle to the apical membrane and to reactivate en-
docytosis. In addition, we showed that gp60 activation
(with cross-linking Ab) also increased 125I-labeled albumin
clearance across endothelial monolayers and the transcel-
lular migration of styryl pyridinium dye-filled vesicles.
Thus, the activation of gp60-induced transcellular mem-
brane traffic was associated with increased transendothe-
lial albumin permeability. However, gp60 activation did
not change the endothelial barrier LP, suggesting that the
interendothelial junctional or paracellular permeability
pathway did not increase when albumin transport was
stimulated by gp60. These physiological experiments pro-
vide further proof that increased albumin permeability af-
ter gp60 activation occurred via a transcellular or nonhy-
draulic permeability pathway.
Caveolae, the nonclathrin-coated pits that are abundant
in vascular endothelial cells, have been implicated in the
mechanism of endocytosis (Lisanti et al., 1994; Anderson,
1998) and transcellular permeability (Milici et al., 1987;
Schnitzer et al., 1994; Tiruppathi et al., 1997). We showed
that gp60 and caveolin-1, the caveolar structural protein
Figure 8. Effects of caveolin-1
overexpression and domi-
nant negative Src (dn-Src) ex-
pression on the association of
Gai and Gaq with caveolin-1.
BLMVEC transfected with
pcDNA3.1 alone (Mock); and
wt-caveolin-1 (cav-1) or dn-
Src was grown to confluence
(48 h posttransfection). Cells
were washed and lysed (see
details in Materials and
Methods), and the lysate was
immunoprecipitated using 2.5
mg/ml anti–caveolin-1 Ab.
Precipitated proteins were
separated by SDS-PAGE and transferred to the Duralose mem-
brane. The membrane was blotted with anti–caveolin-1 Ab (top),
anti-Gai Ab (middle), and anti-Gaq Ab (bottom). Representative
data from three experiments are shown.Minshall et al. Gp60-activated Endothelial Permeability 1067
(Rothberg et al., 1992), were colocalized in endothelial cell
apical plasma membrane–derived vesicles, and that they
migrated in the basolateral direction after activation of gp60.
However, caveolin-1 did not redistribute towards the ba-
solateral membrane to the same extent as gp60, suggesting
that gp60 translocates across the cell mainly, though not
exclusively, with caveolin-1. Immunoprecipitation data
showed that gp60 and caveolin-1 were physically associ-
ated after gp60 activation, which is suggestive of a critical
interaction between gp60 and caveolin-1. Endocytosis of
fluorescent albumin was blocked by filipin, a sterol-bind-
ing agent that dissembles the cholesterol-rich caveolae
(Rothberg et al., 1990, 1992; Schnitzer et al., 1994). Taken
together, these data support the concept that gp60-acti-
vated albumin endocytosis occurs by means of vesicles de-
rived from caveolae. The budding of vesicles may be the
result of dynamin-regulated fission of the caveolar plas-
malemmal membrane (Oh et al., 1998).
Plasmalemmal membrane–derived vesicles have been
shown to contain caveolin-1, G proteins, G protein–cou-
pled receptors, and Src family tyrosine kinases (Chun et al.,
1994; Li et al., 1996; Liu et al., 1996; Murphy et al., 1996;
Song et al., 1997; Zacchi et al., 1998; for review see Ander-
son, 1998). Caveolin-1 is known to sequester caveolae-asso-
ciated signaling proteins such as Src and Gi in their inac-
tive form (Okamoto et al., 1998). As caveolin-1 may be
involved in gp60-induced vesicle formation (Milici et al.,
1987; Tiruppathi et al., 1997), we overexpressed caveolin-1
Figure 9. Effects of caveolin-1
overexpression and dominant
negative  Src (dn-Src) expression
on gp60-induced vesicle forma-
tion. BLMVEC cotransfected
with GFP and either 0.25 mg/ml
vector alone, wt-caveolin-1, or
dn-Src were plated in 4-well
Lab-tek chambers and, at 48 h
after transfection, were assayed
for RH 414 uptake induced by
albumin. Cells were incubated
with 5 mg/ml RH 414 for 15 min
at 378C, rinsed three times in
HBSS (48C), and whole cell fluo-
rescent images of RH 414 were
acquired in GFP-positive cells.
(a and b) BLMVEC transfected
with vector alone; (c and d) cell
transfected with wild type caveo-
lin-1; (e and f) cell transfected
with dn-Src. (a, c, and e) Fluo-
rescein filter set showing a selec-
tion of a GFP-positive (and
cotransfected) cell. (b, d, and f)
Rhodamine filter set showing
whole cell fluorescence of RH
414 from the same field shown in
a, c, or e. Activation of gp60
failed to induce the formation of
vesicles in the cells overexpress-
ing caveolin-1 or expressing dn-
Src. (g and h) Expression of wt-
Src or dn-PKCa had no effect on
RH 414 uptake. Results are rep-
resentative of three to five ex-
periments.The Journal of Cell Biology, Volume 150, 2000 1068
in endothelial cells and addressed the effects of this inter-
vention on vesicle formation after gp60 activation. We ob-
served that caveolin-1 overexpression sequestered Gai
and, importantly, it prevented gp60- activated vesicle for-
mation. This finding is consistent with the role of caveolin-1
in binding (and thereby in sequestering) G proteins and
other signaling molecules (Okamoto et al., 1998). We ad-
dressed the possible role of Gi in activating gp60-induced
vesicle formation using pertussis toxin (Hepler and Gilman,
1992) and the expression of Gai antagonist peptide (Gil-
christ et al., 1998; Ellis et al., 1999). As both inhibitors pre-
vented gp60-activated vesicle formation in endothelial cells,
the results indicate that Gi plays a critical role in transduc-
ing the gp60-induced vesicle formation.
Since Gi induces the activation of downstream Src ki-
nase (Luttrell et al., 1996; Igishi and Gutkind, 1998), we
addressed whether Src kinase was also involved in the
gp60-activated signaling cascade. The results indicated
that the expression of dn-Src prevented gp60-activated
vesicle formation in endothelial cells. Interestingly, dn-Src
expression also prevented the binding of Gai to caveolin-1.
As Src kinase and Gai can compete for a common binding
domain on caveolin-1 (Li et al., 1996; Okamoto et al.,
1998), an explanation for our finding is that binding of dn-
Src to caveolin-1 displaced Gai from caveolin-1. This could
account for the observation that significantly less Gai coim-
munoprecipitated with caveolin-1 in the cells transfected with
dn-Src. The data are consistent with the model that caveo-
lin-1 serves as a scaffolding protein for Gi and Src family
kinases, which activate the signaling machinery mediating
the gp60-induced vesicular transport. Src family tyrosine
kinases activated by receptor dimerization (Marshall, 1995)
or by bg subunits upon stimulation of G-protein–coupled
receptors (Luttrell et al., 1996; Igishi and Gutkind, 1998)
may phosphorylate caveolin-1 (Lisanti et al., 1994; Li et al.,
1996; Tiruppathi et al., 1997) and gp60 (Tiruppathi et al.,
1997), and thereby signal vesicle formation and trafficking.
Thus, the gp60–caveolin-1 complex could function in much
the same manner as G-protein–coupled receptors that in-
teract with Gai and Src.
In summary, we have shown that Gi is required for sig-
naling of vesicle formation in endothelial cells after gp60
activation. Overexpression of wt-caveolin-1 and expres-
sion of dn-Src prevented gp60-induced formation of vesi-
cles. In each case, the role of Gi was important since cave-
olin-1–overexpressing cells sequestered Gai, whereas
dn-Src expression interfered with the binding of Gai to ca-
veolin-1. These results indicate an important role of gp60-
induced activation of the Gi-coupled Src kinase pathway in
signaling the formation of endocytic vesicles and their di-
rected migration to the basolateral surface of the vascular
endothelial barrier.
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